Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

Generator, shock-wave, for pain relief

PMA Number: P080028 · 2020-02-05

ApplicantStorz Medical AG
Decision Date2020-02-05
PMA NumberP080028
Product CodeNBN
Device ClassClass 3
Medical SpecialtyU
Advisory CommitteeSU

Device Summary

Generator, shock-wave, for pain relief is the device name listed in this FDA 510(k) record. The listed applicant is Storz Medical AG. It received FDA 510(k) clearance on 2020-02-05. The device is classified under product code NBN. It was reviewed by the SU advisory panel.

Frequently Asked Questions

What is the Generator, shock-wave, for pain relief?

Generator, shock-wave, for pain relief is a medical device that received FDA 510(k) clearance on 2020-02-05. The listed applicant is Storz Medical AG.

When did Generator, shock-wave, for pain relief receive FDA 510(k) clearance?

The clearance date for Generator, shock-wave, for pain relief can be found in the official FDA records.

Who is the listed applicant for Generator, shock-wave, for pain relief?

The FDA 510(k) record lists Storz Medical AG as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Generator, shock-wave, for pain relief?

The FDA product code for Generator, shock-wave, for pain relief is NBN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑